
News|Articles|July 1, 2004
Estrogen/progestin linked with more severe colorectal cancer
According to a study published in the New England Journal of Medicine, short-term use of estrogen plus progestin significantly decreased the risk of colorectal cancer among postmenopausal women; however, for unknown reasons, the colorectal cancers that did develop in the hormone-treated group were diagnosed at a more advanced stage.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Will the end of enhanced ACA subsidies mean the beginning of a health insurance crisis?
2
Pharmacy leaders in ASHP survey worry about 340B program changes
3
FDA approves first postmenopausal libido treatment, Addyi
4
Johns Hopkins experts warn of potentially severe flu season, measles elimination status faces risk
5


















































